Overcoming Technology Challenges in Decentralized Clinical Trials

Overcoming Technology Challenges in Decentralized Clinical Trials
May 21, 2022 YPrime

Adoption of decentralized clinical trials (DCTs) and other alternatives to conventional clinical trials accelerated in response to the challenges created by Covid-19. Keeping clinical trials on track in the midst of lockdowns and the added strain on the healthcare system encouraged drug development companies to implement new tools to help educate patients about participating in clinical trials, obtain consent, collect patient data, monitor patient compliance, and manage clinical supplies.

In this podcast, Mark Maietta, president of YPrime, talks about examples of technologies that can enable DCTs as well as some challenges sponsors face when implementing technologies for DCTs. He discusses:

  • Factors that have influenced the move toward DCTs
  • Importance of adapting DCT strategies to specific therapeutic areas or indications
  • Considerations when designing a DCT strategy
  • Questions sponsors should ask themselves and their technology partners

Listen to the podcast to hear more about implementing technologies in decentralized clinical trials.

PODCAST

Overcoming Technology Challenges in Decentralized Clinical Trials

Mark Maietta, President

RELATED CONTENT

Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs

Importance of Seeking Patient Insights to Develop Effective Decentralized Clinical Trial Strategies

Importance of Seeking Patient Insights to Develop Effective Decentralized Clinical Trial Strategies

Facilitating DCT with DtP Trial Strategy

Facilitating DCT with DtP Trial Strategy

LATEST CONTENT

Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs

Put the power in the hands of patients with YPrime eConsent

Put the power in the hands of patients with YPrime eConsent

YPrime Launches eConsent Solution